Skip to main content
Clinical Trials/NL-OMON54069
NL-OMON54069
Recruiting
Not Applicable

Electrophysiological markers of cortical excitability to predict response to treatment with anti-seizure medication - The eCORTA Study

Stichting Epilepsie Instellingen Nederland0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Stichting Epilepsie Instellingen Nederland
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • In agreement with their own neurologist to initiate adjuvant treatment with
  • cenobamate, diagnosed with focal epilepsy, age of 18 years or older, having
  • kept a seizure diary for the past 12 weeks, at least one seizure in the past 12

Exclusion Criteria

  • Photosensitive epilepsy, Cochlear implants, implanted neurostimulator or metal
  • in the brain or skull, persistent skull opening following trauma or surgery,
  • cardiac pacemaker, intracardiac lines, evidence (clinical or radiological) of
  • major structural abnormality of the motor cortex or pyramidal tracts, any major
  • psychiatric or neurological (other than epilepsy) condition, pregnancy,
  • learning disabilities.

Outcomes

Primary Outcomes

Not specified

Similar Trials